Dale Sanders, Chief Technology Officer at Health Catalyst, Inc. (HCAT), sold 55,000 shares at $26.03 ($1.4M) on 2020-04-01, disclosed to the SEC on 2020-04-03.
Open-market sale of $1.4M HCAT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.56 | 19,622 | $502K | 35.5% |
| 2 | $25.56 | 19,622 | $502K | 35.5% |
| 3 | $26.03 | 7,878 | $205K | 14.5% |
| 4 | $26.03 | 7,878 | $205K | 14.5% |
| Total | $25.69 avg | 55,000 | $1.4M | 100% |
| Filing → |
| HCAT | SELL | 2020-07-06 | $795K | — | Filing → |
| HCAT | SELL | 2020-06-03 | $742K | — | Filing → |
| HCAT | SELL | 2020-05-05 | $698K | — | Filing → |